Effects of Intravenous Golimumab on Patient-Reported Outcomes in Active Ankylosing Spondylitis: 28-Week Results of the Phase 3 Trial

被引：0

作者：

Reveille, John D. ^{[1
]}

Deodhar, Atul A. ^{[2
]}

Chan, Eric K. H. ^{[3
]}

Peterson, Steven ^{[4
]}

Li, Nan ^{[4
]}

Hsia, Elizabeth C. ^{[5
]}

Kim, Lilianne ^{[4
]}

Lo, Kim Hung ^{[4
]}

Harrison, Diane D. ^{[4
]}

Han, Chenglong ^{[6
]}

机构：

[1] Univ Texas Houston, McGovern Med Sch, Houston, TX USA

[2] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis OP09, Portland, OR 97201 USA

[3] Janssen Global Serv LLC, Raritan, NJ USA

[4] Janssen Res & Dev LLC, Spring House, PA USA

[5] Univ Penn, Janssen Res & Dev LLC, Philadelphia, PA USA

[6] Janssen Global Serv LLC, Malvern, PA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1531

引用

页数：3

共 50 条

[1] EFFECTS OF INTRAVENOUS GOLIMUMAB ON PATIENT-REPORTED OUTCOMES IN ACTIVE ANKYLOSING SPONDYLITIS: 28-WEEK RESULTS OF THE PHASE III GO-ALIVE TRIAL
Reveille, J. D.
Deodhar, A.
Chan, E. K.
Peterson, S.
Li, N.
Hsia, E.
Kim, L.
Lo, K. H.
Harrison, D. D.
Han, C.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1295 - 1296
[2] Improvements in Sleep Problems and Pain in Patients with Active Ankylosing Spondylitis Treated with Intravenous Golimumab: 28-Week Results of the Phase III Trial
Deodhar, Atul A.
Reveille, John D.
Chan, Eric K. H.
Peterson, Steven
Li, Nan
Hsia, Elizabeth C.
Kim, Lilianne
Lo, Kim Hung
Harrison, Diane D.
Han, Chenglong
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[3] IMPROVEMENTS IN SLEEP PROBLEMS AND PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH INTRAVENOUS GOLIMUMAB: 28-WEEK RESULTS OF THE PHASE III GO-ALIVE TRIAL
Deodhar, A.
Reveille, J. D.
Chan, E. K.
Peterson, S.
Li, N.
Hsia, E.
Kim, L.
Lo, K. H.
Harrison, D. D.
Han, C.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 341 - 341
[4] Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial
Reveille, John D.
Deodhar, Atul
Ince, Akgun
Chan, Eric K. H.
Peterson, Steven
Li, Nan
Hsia, Elizabeth C.
Kim, Lilianne
Lo, Kim Hung
Xu, Stephen
Harrison, Diane D.
Han, Chenglong
VALUE IN HEALTH, 2020, 23 (10) : 1281 - 1285
[5] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
Navarro-Compan, V.
Wei, J. C. C.
Van den Bosch, F.
Magrey, M.
Wang, L.
Fleishaker, D.
Cappelleri, J. C.
Wang, C.
Wu, J.
Dina, O.
Fallon, L.
Strand, V.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 704 - 704
[6] SAFETY AND EFFICACY OF INTRAVENOUS GOLIMUMAB IN ADULT PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS THROUGH WEEK 28
Deodhar, A.
Reveille, J. D.
Harrison, D. D.
Kim, L.
Lo, K. H.
Hsia, E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 335 - 335
[7] Safety and Efficacy of Intravenous Golimumab in Adult Patients with Active Ankylosing Spondylitis: Results through Week 28
Deodhar, Atul A.
Reveille, John D.
Harrison, Diane D.
Kim, Lilianne
Lo, Kim Hung
Hsia, Elizabeth C.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[8] Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis A Phase III Randomized Trial (MEASURE 1)
Deodhar, Atul A.
Dougados, Maxime
Baeten, Dominique L.
Wei, James Cheng-Chung
Geusens, Piet
Readie, Aimee
Richards, Hanno B.
Martin, Ruvie
Porter, Brian
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (12) : 2901 - 2910
[9] The effects of etanercept on patient-reported outcomes for subjects with ankylosing spondylitis.
van der Heijde, D
Dougados, M
Davis, JC
Woolley, JM
Tsuji, W
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S174 - S175
[10] THE EFFECT OF GOLIMUMAB, AN ANTI-TNFA MONOCLONAL ANTIBODY, ON GENERAL HEALTH STATUS, DAILY ACTIVITY AND WORK PRODUCTIVITY IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 28-WEEK RESULTS OF THE PHASE III GO ALIVE TRIAL
Reveille, J. D.
Deodhar, A.
Li, N.
Han, C.
Chan, E.
Hsia, E. C.
Kim, L.
Lo, K. H.
Harrison, D. D.
Peterson, S.
VALUE IN HEALTH, 2017, 20 (05) : A151 - A151

← 1 2 3 4 5 →